Today, the KAUST team lead by Prof. Magnus Rueping, Associate Director of the KAUST Catalysis Center was awarded a $2.5M Near Term Grand Challenge award to advance a pan-Betacoronavirus vaccine towards a pre-IND submission with the US FDA.